首页> 外国专利> MEDICINE CAPABLE OF SELECTIVELY STIMULATING GRANULO-MONOCYTOPOIESIS IN CASE OF HYPOPLASIA OF MEDULLARY HEMOPOIESIS TRIGGERED BY CYTOSTATIC

MEDICINE CAPABLE OF SELECTIVELY STIMULATING GRANULO-MONOCYTOPOIESIS IN CASE OF HYPOPLASIA OF MEDULLARY HEMOPOIESIS TRIGGERED BY CYTOSTATIC

机译:静息触发的髓质造血功能减退情况下选择性刺激粒细胞单核细胞增多症的药物

摘要

FIELD: medicine. SUBSTANCE: this drug capable of selectively stimulating granulo-monocytopoiesis in case of hypoplasia of medullary hemopoiesis caused by cytostatic may find application in medical institutions employing antitumoral drugs for treating cytostatic hemodepressions. Essence of this method resides in using glucuronic acid, substance already known in the art, for new purposes as drug capable of selectively stimulating granulo-monocytopoiesis in case of hypoplasia of medullary hemopoiesis caused by cytostatic with the aim of reducing toxic effect of cytostatics on hemopoiesis due to stimulation of granulo-monocytopoiesis. EFFECT: excellent medicine capable of selectively stimulating granulo-monocytopoiesis. 3 dwg, 6 tbl
机译:领域:医学。物质:这种能够在细胞抑制引起的髓性造血发育不全的情况下选择性刺激颗粒单核细胞生成的药物可能会在使用抗肿瘤药物治疗细胞抑制性降压的医疗机构中得到应用。该方法的实质在于使用葡萄糖醛酸(本领域已知的物质)作为新的目的,作为能够在由细胞抑制剂引起的髓性造血细胞发育不全的情况下选择性刺激粒状单核细胞增多的药物,目的是减少细胞抑制剂对血细胞生成的毒性作用。由于刺激了颗粒单核细胞增多。功效:能够选择性刺激颗粒单核细胞增多的优秀药物。 3桶,6桶

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号